Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | CPA1 | P15085 | 1/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12448296 | 0.82 | ALDH1A1 (0.46) | ALDH1A1TDP1 | |
| SCHEMBL14011111 | 0.82 | MMP9 (0.33) | MMEACECPA1ACE2 | |
| SCHEMBL23643228 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TDP1MMEACECPA1 | |
| SCHEMBL17953988 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TDP1MME | |
| SCHEMBL29307827 | 0.78 | ALDH1A1 (0.41) | ALDH1A1ACE | |
| SCHEMBL24899933 | 0.78 | ALDH1A1 (0.38) | ALDH1A1TDP1MME | |
| SCHEMBL7995489 | 0.76 | MME (0.46) | ALDH1A1TDP1MME | |
| SCHEMBL23643116 | 0.75 | ALDH1A1 (0.39) | ALDH1A1TDP1ACE | |
| SCHEMBL13058954 | 0.75 | ALDH1A1 (0.48) | ALDH1A1TDP1MMEACE | |
| SCHEMBL15274733 | 0.74 | MME (0.33) | MMEACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | CD2BP2, DCLRE1A, EPCAM | ALDH1A1 618/4885TDP1 3390/4885MME 2501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.